Supplemental Financial Information (Tables)

3 Months Ended

Mar. 29, 2026

Organization, Consolidation and Presentation of Financial Statements [Abstract]

The following table presents revenue disaggregated by sales channel:


	For the three months ended
	March 29, 2026	March 30, 2025
Distributors	1,862	1,524
Direct	1,282	1,284
Other	37	27
Total - Revenue	3,181	2,835

Schedule of Depreciation, Amortization and Impairment


	For the three months ended
	March 29, 2026	March 30, 2025
Depreciation of property, plant and equipment	109	143
Amortization of internal use software	13	8
Amortization of other identified intangible assets	57	58
Total - Depreciation, amortization and impairment	179	209

Schedule of Financial Income and Expense


	For the three months ended
	March 29, 2026	March 30, 2025
Interest income	31	35
Interest expense	(114)	(106)




Other financial income (expense)	(13)	(21)
Total - Financial income (expense)	(96)	(92)

Schedule of Earnings Per Share

The computation of earnings per share (EPS) is presented in the following table:


	For the three months ended
	March 29, 2026	March 30, 2025
Net income (loss)	1,133	497
Less: net income (loss) attributable to non-controlling interests	11	7
Net income (loss) attributable to stockholders	1,122	490

Weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands)	252,715	253,709
Plus incremental shares from assumed conversion of:
Options 1)	4	94
Restricted Share Units, Performance Share Units and Equity Rights 2)	806	1,215
Dilutive potential common shares	810	1,309

Adjusted weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands)	253,525	255,018

EPS attributable to stockholders in $:
Basic net income (loss)	4.44	1.93
Diluted net income (loss)	4.43	1.92

1) There were no stock options to purchase shares of NXP’s common stock that were outstanding in Q1 2026 (Q1 2025: no stock options to purchase shares) that were anti-dilutive and were not included in the computation of diluted EPS because the exercise price was greater than the average fair market value of the common stock or the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense and exercise prices were greater than the weighted average number of shares underlying outstanding stock options.

2) There were no unvested RSUs, PSUs and equity rights that were outstanding in Q1 2026 (Q1 2025: no unvested RSU's, PSU's and equity rights) that were anti-dilutive and were not included in the computation of diluted EPS because the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense were greater than the weighted average number of outstanding unvested RSUs, PSUs and equity rights or the performance goal has not been met.

Schedule of Inventories

Inventories are summarized as follows:


	March 29, 2026	December 31, 2025
Raw materials	97	92
Work in process	1,802	1,778
Finished goods	624	707
	2,523	2,577

Schedule of Equity Investments

At March 29, 2026, and December 31, 2025, the total carrying value of investments in equity securities is summarized as follows:


	March 29, 2026	December 31, 2025
Marketable equity securities	2	1
Non-marketable equity securities	162	118
Equity-accounted investments	1,017	826
	1,181	945

Schedule of Carrying Value of Investments in Equity-Accounted Investees

The total carrying value of investments in equity-accounted investees is summarized as follows:


	March 29, 2026			December 31, 2025
	Shareholding %		Amount	Shareholding %		Amount
VisionPower Semiconductor Manufacturing Company Pte. Ltd. (VSMC)	40.00	%	817	40.00	%	623
European Semiconductor Manufacturing Company (ESMC) GmbH 1)	10.00	%	176	10.00	%	180


Others	—		24	—		23
			1,017			826
1) NXP accounts for its investment in ESMC under the equity method due to our ability to exercise significant influence over ESMC’s operations, primarily through representation on ESMC’s shareholders’ committee and other operational arrangements.

Schedule of Results Relating to Equity-Accounted Investees

Results related to equity-accounted investees at the end of each period were as follows:


	For the three months ended
	March 29, 2026	March 30, 2025
Company's share in income (loss)	(4)	(4)
Other results	—	—
	(4)	(4)

Schedule of Other Current Liabilities

Other current liabilities at March 29, 2026, and December 31, 2025, consisted of the following:


	March 29, 2026	December 31, 2025
Accrued compensation and benefits	470	393
Dividend payable	256	256
Customer programs	150	57
Income taxes payable	260	83
Other	715	656
	1,851	1,445

Schedule of Accumulated Other Comprehensive Income (Loss)

The after-tax components of accumulated other comprehensive income (loss) and their corresponding changes are shown below:


	Currency translation differences	Change in fair value cash flow hedges	Net actuarial gain/(losses)	Accumulated Other Comprehensive Income (loss)
As of December 31, 2025	247	2	(36)	213
Other comprehensive income (loss) before reclassifications	(37)	(3)	(1)	(41)
Amounts reclassified out of accumulated other comprehensive income (loss)	—	(2)	—	(2)
Tax effects	—	1	—	1
Other comprehensive income (loss)	(37)	(4)	(1)	(42)
As of March 29, 2026	210	(2)	(37)	171

Schedule of Cash Dividends

The following dividends were declared during the first three months of 2026 and 2025 under NXP’s quarterly dividend program:

Fiscal Year 2026

Fiscal Year 2025

Dividend per share

Amount

Dividend per share

Amount

First quarter

1.014

256

1.014

257